Objectives To examine temporal trends in the incidence and recurrence of hospitalised coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral arterial disease (PAD) separately and combined, and by the history of all forms of atherothrombotic disease (ATD).
Design Population-based longitudinal data linkage study.
Setting Western Australia.
Participants All patients aged 35–84 years hospitalised in Western Australia for CHD, CeVD or PAD from 2000 to 2007.
Main Outcome Measures Age-standardised incidence and recurrence rates of CHD, CeVD and PAD stratified by ATD history, sex and age.
Results 107 576 events (65.9% men) were identified; 70% of all admissions were for CHD. In patients without a history of any ATD, incidence rates declined significantly in all groups, although the reduction in incident CHD in women was marginal (−0.7%/year, 95% CI −1.5 to +0.1%). The largest annual reductions in incidence rates were for PAD (men, −6.4%/year, 95% CI −7.7 to −5.0%; women, −5.4%/year, 95% CI −7.2 to −3.6%) and CeVD in women (−4.0%/year, 95% CI −5.0 to −3.0%). Falls in overall recurrence rates were greatest for CeVD (men, −3.2%/year, 95% CI −4.7 to −1.6%; women −4.6%/year, 95% CI −6.4 to −2.7%). Trends across all categories of polyvascular ATD were generally downward, although not all changes were statistically significant.
Conclusion The incidence and recurrence rates of hospitalised ATD have decreased over time, including in patients with disease involving multiple vascular territories. This implies that primary and secondary prevention strategies have been broadly effective. However, high absolute rates of recurrence and limited reduction in 35–54-year-old individuals highlight patient groups to target to reduce further the burden of ATD.
- Acute coronary syndrome
- cerebrovascular disorders
- coronary artery disease
- coronary heart disease
- myocardial ischaemia and infarction (IHD)
- peripheral artery disease
- public health
- quality of care and outcomes
- risk factors
Statistics from Altmetric.com
Funding LN is funded by the National Health and Medical Research Council of Australia (NHMRC); the NHMRC funded the Real and Changing Atherothrombotic Disease Burden and Secondary Prevention project (#572558); the funding body played no role in the study design, analysis or interpretation of data, writing of the report, or of the decision to submit the article for publication.
Competing interests None.
Ethics approval This study was approved by the ethics committees of the University of Western Australia (RA/4/1/1491) and the WA Department of Health (#2009/18).
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.